Keyphrases
Accelerated Atherosclerosis
9%
Activity Measurement
9%
Adjusted Odds Ratio
18%
African American
36%
Allele Frequency
18%
Antiprothrombin Antibodies
9%
Antithrombin Activity
9%
Cardiac Events
27%
Cardiovascular Events
9%
Caucasian American
27%
Coagulation Factor II
100%
Female Control
9%
Functional Polymorphism
100%
G20210A
9%
Gene Polymorphism
9%
High Activity
9%
High Prevalence
9%
High Risk
9%
Inflammatory Immune Response
9%
Inflammatory System
9%
Odds Ratio
9%
Patient-centered
9%
Polymorphism
9%
Prothrombin
18%
Rheumatology
9%
Systemic Lupus Erythematosus
100%
Systemic Lupus Erythematosus Patient
9%
Thrombosis Risk
18%
Vascular Events
27%
Medicine and Dentistry
Allele
16%
Atherosclerosis
8%
Blood Clotting Factor
100%
Cardiovascular System
8%
DNA Polymorphism
8%
Gene Frequency
16%
Hemostat
8%
Immunity
8%
Odds Ratio
25%
Prevalence
8%
Prothrombin
100%
Prothrombin Antibody
8%
Rheumatology
8%
Systemic Lupus Erythematosus
100%
Thrombosis
16%
Biochemistry, Genetics and Molecular Biology
Allele
50%
Blood Coagulation Factor
100%
Gene Frequency
50%
Gene Polymorphism
25%
Immunity
25%
Prevalence
25%
Prothrombin
100%
Neuroscience
Allele Frequency
16%
Blood Clotting Factor
100%
DNA Polymorphism
8%
Prothrombin
100%
Prothrombin Antibody
8%
Rheumatology
8%
Systemic Lupus Erythematosus
100%
Immunology and Microbiology
Allele
16%
Atherosclerosis
8%
DNA Polymorphism
8%
Gene Frequency
16%
Immunity
8%
Prevalence
8%
Prothrombin Antibody
8%
Systemic Lupus Erythematosus
100%